HOME >> BIOLOGY >> NEWS
Epigenetic studies will provide a better understanding of disease

From 26-28 March, the Institute for Research in Biomedicine (IRB Barcelona) will bring together 20 internationally recognised scientists from the USA and Europe working in epigenetics to present their latest work. Invited by Ferran Azorn, principal investigator at IRB Barcelona, and Tony Kouzarides, director of the Gurdon Institute in the United Kingdom, these scientists will participate in a new Barcelona BioMed Conference, one of a series organised jointly by IRB Barcelona and the BBVA Foundation. The conference will be held in the Auditorium (Tower D) of the Barcelona Science Park.

Epigenetics emerged on the scene in the 1990s. Researchers discovered that chromatin, the complex formed by DNA and histones, -proteins that bind strongly to DNA, thereby packaging it in chromosomes-, regulate gene expression. This additional layer of regulatory instructions, which are not held in DNA, comprise the epigenetic code.

Epigenetic differences explain, for example, why two cloned organisms are not the same or why twins develop illnesses of distinct genetic origin. Epigenetic studies promise not only to have a direct impact on health and our understanding of the relations between the environment and genetics but also to provide an explanation of basic aspects of cell biology. The co-organiser of the conference, Ferran Azorn, head of the "Chromatin Structure and Function" group at IRB Barcelona, comments that "deciphering and understanding the epigenome will shed light on fundamental processes in cell physiology. This knowledge will improve our understanding of the development of tumours and other diseases, and may lead to the design of new treatments for these conditions". A new family of epigenetic drugs, designed to reverse the changes in the epigenome that occur during the development of several kinds of cancer, is currently available. Several of these pharmacological agents are now being used to treat some types of leukaemia and breast cancer.


'"/>

Contact: Snia Armengou
sarmengou@pcb.ub.es
34-934-037-255
Institute for Research in Biomedicine (IRB)
19-Mar-2007


Page: 1 2

Related biology news :

1. Epigenetics to shape stem cell future
2. Epigenetic drugs, promising for breast cancer treatment
3. New view of cancer: Epigenetic changes come before mutations
4. Epigenetic activity silences Rb2/P130 gene in lung cancer
5. New studies on goats milk show it is more beneficial to health than cows milk
6. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
7. Obtaining valid consent for doing large genetic studies in developing countries
8. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
9. New studies link the environment to Parkinsons disease
10. Ewwwww! UCLA anthropologist studies evolutions disgusting side
11. Genetic studies endow mice with new color vision

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... ... in the global health and medical technology market, announced that it has selected ... / Robotics Solution” award in the 2019 MedTech Breakthrough Awards program. , ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, ... financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... platform that provides services to more than one dozen hospitals and surgery centers ...
(Date:6/4/2019)... ... June 04, 2019 , ... ... the appointment of Susan Murphy as the new President of Molecular Devices, replacing ... Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in a ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... application to the FDA for use of a person’s own adipose-derived stem cells to ... osteoarthritis in the knee. This IND is the first of several planned clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine company, ... , has announced that their GMP facility for cell production is now approved ... This is an important milestone for VetStem as it expands into contract ...
(Date:5/31/2019)... (PRWEB) , ... May 29, 2019 , ... For many ... the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led to ... patient’s own T cells with engineered T cell receptors known as “CARs”. The CAR ...
Breaking Biology Technology:
Cached News: